Elevra revenue jumps 39% to $202 million ahead of September report
Key Facts
Elevra Lithium had not published its activity report for the quarter ended in September 2026 when the draft was published on October 26; the company had set October 27 as the release date, according to its official investor page. The available information therefore does not support the claim that first-quarter 2026 results beat market expectations or that the company’s shares rose in response to those results. Nor does it substantiate the draft’s trading range or its connection to the company’s performance. The forthcoming announcement is described as a quarterly activity report, not first-quarter 2026 financial results. The latest financial comparisons cited here remain those for the fiscal year ended in June 2026.
In its fiscal 2026 results, Elevra reported revenue of $202 million, up 39% from $145 million in the previous year, according to results filed with the U.S. Securities and Exchange Commission. The figures compare the year ended June 30, 2026, with the year ended June 30, 2025. The comparison shows annual revenue growth, but does not represent results for the quarter ended in September. It also provides no market forecasts that could support a claim that performance exceeded analyst estimates. The activity report scheduled for the day after the draft will cover a period later than those annual results.
On net income, the company turned a profit after tax of $44 million in fiscal 2026, after recording a loss of $247 million in fiscal 2025, according to the same filing. The change puts annual profitability in a different context from revenue growth alone, comparing a positive result with a loss in the prior year. The group had cash of $255 million on June 30, 2026, compared with $47 million at the end of the comparable period, according to the results table. This shows an increase in liquidity between the two periods, while the figures remain tied to the end of June and do not reveal the cash position at the end of September. They therefore provide background on the financial position ahead of the forthcoming quarterly report.
In its operations, spodumene concentrate production fell 3% in fiscal 2026 to 197,967 dry metric tons, from 204,858 tons in the previous year, according to the company’s results. By contrast, the average realized selling price on a free-on-board basis rose 57% to $1,092 per dry metric ton, compared with $694. Together, the figures show a slight decline in production volume and an increase in the average realized selling price during the annual period. But on their own, they do not show production volumes or prices for the quarter ended in September, whose activity report investors are awaiting. Chief Executive Lucas Dow said the sale of the company’s stake in the Ewoyaa project “improves financial flexibility and allows us to focus our strategy on our North American assets,” according to the sale announcement filed with the commission.
Elevra describes itself as a lithium producer and developer listed on the Australian and Nasdaq markets, according to its official investor page. On October 8, the company announced it had signed a spodumene supply agreement with LG Energy Solution, a commercial development that preceded the quarterly report date, but the available announcement does not provide quantitative terms for the agreement. For fiscal 2027, Elevra issued guidance for production of between 198,000 and 210,000 dry metric tons of spodumene concentrate, and sales of between 200,000 and 230,000 tons. These ranges set out the company’s targets for the coming period alongside production and sales figures recorded in fiscal 2026. The guidance does not represent actual results for the quarter ended in September.
After the scheduled release of the September activity report on October 27, 2026, the company’s calendar lists its annual general meeting on November 19, 2026. It also sets February 25, 2027, as the date for its half-year results announcement, according to the investor page. The two dates provide the next milestones in the company’s disclosure calendar, with the imminent quarterly report remaining the first scheduled update after the end of September. The available information does not establish share-price movement or the market’s reaction to the forthcoming report. Any assessment of the quarter’s performance remains dependent on the report’s release and the actual data it contains.